RNASET2 and rheumatoid arthritis: The circulating levels of RNASET2 resulted increased in our cohort of RA patients compared with healthy controls, mirroring the behaviour of a prototypical inflammatory cytokine, IL-6, which plays a central role in the pathogenesis of RA52.